Topic - National Cancer Institute

The National Cancer Institute (NCI) is part of the United States Federal government's National Institutes of Health. The NCI is a federally funded research and development center and one of the agencies that compose the Public Health Service in the United States Department of Health and Human Services. The NCI coordinates the National Cancer Program. As of July 2010, the current director of the NCI is Dr. Harold Varmus. - Source: Wikipedia

Related Stories

A box of ivermectin is shown in a pharmacy as pharmacists work in the background in Georgia, on Thursday, Sept. 9, 2021. (AP Photo/Mike Stewart, File)

Why is ivermectin’s potential as a cancer drug being quashed?

By Anath Hartmann - The Washington Times

Oksana Halak poses for a portrait with her son Dmytro, 2, at the National Cancer Institute in Kyiv, Ukraine, Wednesday, July 10, 2024. Dmytro is one of 31 young patients battling cancer who were relocated to the hospital from Okhmatdyt Children’s Hospital after it was struck by a Russian missile this week. (AP Photo/Alex Babenko)

Russian missile attack on Ukraine’s largest hospital complicates treatment of kids with cancer

By Hanna Arhirova - Associated Press

The UK Markey Cancer Center has been named a comprehensive cancer center from the National Cancer Institute in Lexington, Ky., Tuesday, Sept. 12, 2023. State and university leaders gathered in Lexington on Friday, Sept. 15, to celebrate the Markey Center's designation. (Silas Walker/Lexington Herald-Leader via AP)

University of Kentucky cancer center achieves highest designation from National Cancer Institute

By Bruce Schreiner - Associated Press

First lady Jill Biden, middle right, gestures while speaking with Dr. Alan Ashworth, clockwise from left, Dr. Paola Betancur, Dr. Monica Bertagnolli, Kami Pullakhandam, hidden, Dr. Rita Mukhtar, Dr. Laura Huppert and Rep. Jackie Speier, D-Calif., during a visit to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) ** FILE **

Biden taps Dr. Monica Bertagnolli, a top cancer researcher, to lead NIH

By Tom Howell Jr. - The Washington Times

FILE - This July 16, 1945 photo, shows an aerial view after the first atomic explosion at Trinity Test Site, N.M. A defense spending bill pending in Congress includes an apology to New Mexico, Nevada, Utah and other states affected by nuclear testing over the decades, but communities downwind from the first atomic test in 1945 are still holding out for compensation amid rumblings about the potential for the U.S. to resume nuclear testing. (AP Photo/File)

Study: Cancer cases likely in those exposed to atomic test

By SUSAN MONTOYA BRYAN - Associated Press

$13.6M for cancer clinical trials in Louisiana, Mississippi

By JANET McCONNAUGHEY - Associated Press

University of Miami cancer center receives NCI designation

By the Associated Press - Associated Press

$11M grant seeks to prevent cervical cancer in Appalachia

Associated Press

This 2018 photo made available by the National Cancer Institute shows Dr. Norman E. Sharpless. On Tuesday, March 12, 2019, The Food and Drug Administration announced that Sharpless will temporarily take charge of the agency after the unexpected departure of its current chief, Scott Gottlieb. (H. Darr Beiser/NCI via AP)

NIH cancer chief to serve as acting FDA commissioner

By MATTHEW PERRONE - Associated Press

FILE - This July 16, 1945 photo, shows the mushroom cloud of the first atomic explosion at Trinity Test Site, New Mexico. The National Cancer Institute says its long-anticipated study into the cancer risks of New Mexico residents living near the site of the world's first atomic bomb test likely will be published in 2019. Institute spokesman Michael Levin told The Associated Press that researchers are examining data on diet and radiation exposure and expect to finish the study by early next year. (AP Photo, File)

Cancer study of nuclear test site expected to finish in 2019

By RUSSELL CONTRERAS - Associated Press

In this photo taken March 29, 2017, Dr. David Maloney of the Fred Hutchinson Cancer Research Center is greeted by patient Ken Shefveland, whose lymphoma was successfully treated with CAR-T cell therapy. Immune therapy is the hottest trend in cancer care and its next frontier is creating &quot;living drugs&quot; that grow inside the body into an army that seeks and destroys tumors. (AP Photo/Elaine Thompson)

Doctors reprogram patients’ own cells into cancer assassins

By LAURAN NEERGAARD - Associated Press

Kansas City-based health system signs cancer trial agreement

Associated Press

APNewsBreak: Texas cancer probe draws NCI scrutiny

By PAUL J. WEBER - Associated Press

FDA panel backs Glaxo drug for rare cancer

By MATTHEW PERRONE - Associated Press

FDA panel backs Glaxo drug for rare sarcoma cancer

By MATTHEW PERRONE - Associated Press